webinar register page

PHYSICIAN ENTERPRISES AFTER COVID-19: CAPTURING AND ASSESSING OPPORTUNITIES
Physician enterprises will face lasting changes to their operations following the Coronavirus (COVID-19) public health emergency. Transactional opportunities have also shifted, and physician enterprises and their counterparts have new factors to consider when assessing and pursing collaborations, and other transactions in a post-COVID-19 world.

Joined by leaders from Providence St. Joseph Health, DMG Physician Organization, Golden State Dermatology, SullivanCotter and Veralon Partners, McDermott Will & Emery will lead the conversation on how physician enterprises can position themselves for success in the new healthcare landscape.

This program will explore:

• How has COVID-19 changed the healthcare and investing landscape?
• How can physician practices shift their means of care delivery, including telehealth solutions, now and after COVID-19?
• How have operational challenges impacted physician practice valuations?
• What transactional opportunities have arisen from the public health emergency?
• How can physician enterprises and their counterparts execute successful strategic collaborations?

SPEAKERS

Kevin Manemann, Executive Vice President, Chief Executive, Physician Enterprise, Providence St. Joseph Healthcare

Kyle Tormoehlen, Principal, SullivanCotter

Paul F. Merrick, MD, Chairman of the Board, DMG Physician Organization

John Harris, MBA, Director, Veralon Partners

Daniel Koob, Chief Development Officer, Golden State Dermatology

Aug 6, 2020 03:00 PM in Eastern Time (US and Canada)

Webinar logo
Webinar is over, you cannot register now. If you have any questions, please contact Webinar host: Laura McAllister.